The long-term evolution of chronic hepatitis B acquired in childhood. 2009

Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
1st Medical Clinic, str. Clinicilor Nr. 3-5, 400006 Cluj-Napoca, Romania. roberta786@yahoo.com

The AIM of this study was to assess the long-term evolution of chronic hepatitis B acquired in childhood. METHODS The study was carried out in 2007 - 2008 on a group of 77 adult patients who were diagnosed with chronic hepatitis B in childhood. The actual assessment included epidemiological, clinical, biological and virological data, ultrasound examination in all patients and liver histology in 3 patients. RESULTS From the 77 patients, 69 were HBeAg positive and the other 8 patients were anti-HBe positive when the diagnosis was made in their childhood. Thirty-seven patients from the HBeAg positive group and 2 patients from the anti-HBe group had been treated in childhood with IFN-alpha and the other 38 patients remained untreated (32 patients with HBeAg positive and 6 patients anti-HBe positive). Overall, 78.26% seroconverted to anti-HBe (87.50% untreated and 70.27% of patients treated with IFN). After a median follow-up period of 13 years, 36 patients from the HBeAg positive group (48.65% of treated patients and 56.25% of untreated ones) became inactive carriers. Seroconversion to anti-HBs, in the HBeAg positive group, occurred in 10.14% of cases (8.1% in treated patients) without statistical significance. Three patients from the whole group developed cirrhosis but none developed hepatocellular carcinoma. CONCLUSIONS The long-term outcome in our patients with CHB acquired in childhood did not differ between treated and untreated patients.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection

Related Publications

Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
January 1992, Archives of virology. Supplementum,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
December 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
June 2014, Turk pediatri arsivi,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
January 2011, Annals of hepatology,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
September 2010, Gastroenterologie clinique et biologique,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
April 1990, The Journal of pediatrics,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
January 1984, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
September 1990, Gastroenterology,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
January 1991, Journal of gastroenterology and hepatology,
Roberta M Manzat Saplacan, and Petru A Mircea, and Simona D Valean, and Nicolae Miu, and Lucia Burac, and Cornel Valean, and Mircea Nanulescu
July 1999, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!